Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study-Reference-Cited by-同舟云学术

Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study

Published:2017-01-15 Issue:1 Volume:11 Page:129-135
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Cho Eun Young¹,Yim Hyung Joon²,Jung Young Kul²,Suh Sang Jun²,Seo Yeon Seok³,Kim Ji Hoon³,Kim Hong Soo⁴,Lee Sae Hwan⁴,Ahn Sang Hoon⁵,Lee Jeong Il⁵,Jeong Sook-Hyang⁶,Kim Jin-Wook⁶,Lee Jin-Woo⁷,Kim In Hee⁸,Kim Hyoung Su⁹,Park Sang Jong¹⁰,Lee Jeong Mi¹¹,Hwang Seong Gyu¹²,

Affiliation:

1. Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea

2. Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea

3. Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

4. Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea

5. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

6. Department of Internal Medicine, Seoul National University College of Medicine, Seongnam, Korea

7. Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea

8. Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea

9. Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea

10. Bundang Jesaeng Hospital, Seongnam, Korea

11. Department of Public Health, Wonkwang University Graduate School, Iksan, Korea

12. Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2017/011/ekjg011-01-20.pdf

Reference32 articles.

1. A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B

2. Clevudine Therapy for 24 Weeks Further Reduced Serum Hepatitis B Virus DNA Levels and Increased ALT Normalization Rates without Emergence of Viral Breakthrough than 12 Weeks of Clevudine Therapy

3. Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B

4. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression

5. Efficacy of 48-week clevudine therapy for chronic hepatitis B

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B;The Korean Journal of Gastroenterology;2021-01-25

2. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants;Medicinal Research Reviews;2018-02-06

3. New treatments to reach functional cure: Virological approaches;Best Practice & Research Clinical Gastroenterology;2017-06